Dual-specificity protein tyrosine phosphatase localized to mitochondrion 1 (PTPMT1) has recently proved to be a promising therapeutic target for the treatment of type II diabetes. Herein we report the first example for a successful application of the structure-based virtual screening to identify the novel inhibitors of human PTPMhese inhibitors were computationally screened for having desirable physicochemical properties as a drug candidate and reveal a high potency with IC5values ranging from .7 to 17.3 μM. Therefore, they deserve consideration for further development by structure-activity relationship studies to optimize the antidiabetic activities. Structural features relevant to the stabilization of the newly identified inhibitors in the active site of PTPMT1 are addressed in detail..
Related Content
Discovery of Tyrosine Kinase Inhibitors by Docking into an Inactive Kinase Conformation Generated by Molecular Dynamics
Several small molecules that bind to the inactive DFG-out conformation of tyrosine kinases (called type II inhibitors) have shown a good selectivity profile over other kinase targets. To obtain a set of DFG-out structures, we performed an explicit solvent molecular dynamics (MD) simulation of t...


New scaffolds of natural origin as Integrase–LEDGF/p75 interaction inhibitors: Virtual screening and activity assays
The disruption of crucial interactions between HIV-1 Integrase and cellular cofactor LEDGF/p75 represents an emerging approach for the design and development of new antiretroviral agents. In this study we report the successful application of a structure-based virtual screening strategy for the di...
Computational Studies Identifying Entry Inhibitor Scaffolds Targeting the Phe 43 Cavity of HIV-1 gp120
Targeting protein–protein interactions, such as the HIV-1 gp120—CD4 interface, has become a cutting-edge approach in the current drug discovery scenario. Many small molecules have been developed so far as inhibitors of the interaction between CD4 and HIV-1 gp120. However, due to a variety of ...


Discovery of potent small molecule inhibitors of DYRK1A by structure-based virtual screening and bioassay
In this study, six novel dual-specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) inhibitors with IC5values ranging from 1.51 to 88.13μM were successfully identified through virtual screening andin vitroplus cell based bioassay. Compound5with IC5value of 1.51μM is the most potent ...
Structure-Based Virtual Screening Approach to the Discovery of p38 MAP Kinase Inhibitors
P38 mitogen-activated protein kinase (MAPK) has been considered to be a promising target for the development of therapeutics for various immunologic diseases. Herein we report an example for a successful application of the virtual screening with protein-ligand docking to identify the novel inhibi...

Progresses in the Pursuit of Aldose Reductase Inhibitors: The Structure-Based Lead Optimization Step
Aldose Reductase (ALR2) is a crucial enzyme in the development of the major complications of diabetes mellitus. Very recently it has been demonstrated that the ARL2 inhibitor, fidarestat, significantly prevents inflammatory signals (TNF-α, LPS) that cause cancer (colon, breast, prostate and lung...
Deorphanization of Malonyl CoA:ACP Transacylase Drug Target in Plasmodium falciparum (PfFabD) Using Bacterial Antagonists: A ‘Piggyback’ Approach for Antimalarial Drug Discovery
Quest for new drug targets in Plasmodium sp. has underscored malonyl CoA:ACP transacylase (PfFabD) of fatty acid biosynthetic pathway in apicoplast. In this study, a “piggyback” approach was employed for the receptor deorphanization using inhibitors of bacterial FabD enzymes. Due to the lack ...

Alzheimer’s Disease: Identification and Development of β-Secretase (BACE-1) Binding Fragments and Inhibitors by Dynamic Ligation Screening (DLS)
The application of dynamic ligation screening (DLS), a methodology for fragment-based drug discovery (FBDD), to the aspartic protease β-secretase (BACE-1) is reported. For this purpose, three new fluorescence resonance energy transfer (FRET) substrates were designed and synthesized. Their kineti...
Discovery of novel human acrosin inhibitors by virtual screening
Human acrosin is an attractive target for the discovery of male contraceptive drugs. For the first time, structure-based drug design was applied to discover structurally diverse human acrosin inhibitors. A parallel virtual screening strategy in combination with pharmacophore-based and docking-bas...

Substructure-Based Virtual Screening for Adenosine A2A Receptor Ligands
A virtual ligand-based screening approach was designed and evaluated for the discovery of new A2A adenosine receptor (AR) ligands. For comparison and evaluation, the procedures from a recently published virtual screening study that used the A2A AR X-ray crystal structure for the target-based disc...